Taylor & Francis Group LLC / Northern Lipids Inc. / /
Country
Canada / /
Currency
pence / CRC / /
Facility
stable PEG / NA complex / /
IndustryTerm
in vitro cell culture systems / passive disease site / encapsulated systems / utilized passive loading technology / model membrane systems / pharmaceutical development / target site / disease site / lipoplex systems / gene therapy applications / antiinfective applications / lipid solution / delivery solution / lipid-containing systems / aqueous media / formulation technology / intracellular site / chemical and biological properties / charged systems / nontarget systems / aqueous solution / liposomal systems / nucleic acid solution / lipid-containing lipoplex systems / /
Organization
EPC / Systemic Administration / ND ND / /
Person
Ian MacLachlan / /
Position
casual investigator / /
Product
polyethylene glycol / Vitamin D / /
Technology
gene therapy / Pharmacokinetics / drug delivery / 240 ANTISENSE DRUG TECHNOLOGIES / utilized passive loading technology / antibodies / siRNA / 238 ANTISENSE DRUG TECHNOLOGIES / 246 ANTISENSE DRUG TECHNOLOGIES / formulation technology / 244 ANTISENSE DRUG TECHNOLOGIES / 242 ANTISENSE DRUG TECHNOLOGIES / dialysis / /
CRC_8796_ch009.qxd:43 PM